Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Next-gen Medical Education Technologies to Keep an Eye on in 2025

June 4, 2025 | AI, CME tools, HCP education, HCP engagement, HCP training, Impetus Digital, Med ed AI, Med ed trends, Online training, Virtual training, artificial intelligence, digital tools, digital training, education trends, med ed, med ed tools, medical education, pharma tools, training tools, virtual education 

Dive into 2025’s cutting-edge medical education technologies like immersive training, interactive data visualization, and microlearning. Discover how to boost engagement and drive real HCP impact.

- PMLiVE

While opportunities for continuing education and Pharma-sponsored learning programs are always welcome by healthcare providers (HCPs), it is no secret that traditional HCP education is plagued by a range of issues. Among many others, these include limited participant engagement and retention, suboptimal interaction due to didactic formats, no or low ability to personalize, and the content being too generic or outdated as a result of rapid medical advancements. In addition, HCPs are increasingly demanding flexible learning opportunities. Luckily, recent years have seen a shift in how life science companies educate and train HCPs, with a myriad of novel tools available to help overcome these challenges.

Building on my recent exploration of the top medical education trends of 2024, here, we’re diving into the most anticipated next-generation tools that will take medical education to new levels in 2025.

Read it now

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...

Versatility! Top 10 benefits of virtual advisory boards

Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform...

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story

In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning Longitudinal Expert Engagement Plan™ (LEEP™) to conduct an informal...

New Playbook Alert: Virtual Patient Engagement

Authentic patient engagement and insight-gathering are becoming must-haves in Pharma. However, multiple obstacles remain before patient-centricity becomes more than a buzzword. In our latest playbook, we take a deep dive...